Table 1. Characteristics of studies included in the meta-analysis for an association between XPF-rs1800067, rs1799801, rs2020995, rs744154 SNPs and risk of cancers.
First author, Year | Cancer type | Country | Ethnicity | Study type | Source of control | Cases/Controls | MAF of controls | P a | Powerb | Source of DNA | Genotyping methods |
XPF-rs1800067 (Arg415Gln) | |||||||||||
Yu, submitted | Head neck | USA | Caucasian | Retrospective | HB | 1040/1046 | 0.11 | 0.485 | 0.999 | Blood | SNPlex, PCR-RFLP, Quantitative PCR |
Doherty, 2011 | Endometrial | USA | Caucasian | Retrospective | PB | 703/714 | 0.07 | 0.184 | 0.925 | Blood, Buccal cells | SNPlex, SNaPshot, Quantitative PCR, PCR-RFLP |
Gil,2011 | Colorectal | Poland | Caucasian | Retrospective | HB | 133/98 | 0.08 | 0.281 | 0.533 | Lymphocytes | PCR-RFLP |
Krupa, 2011 | Larynx | Poland | Caucasian | Retrospective | HB | 253/253 | 0.06 | 0.682 | 0.876 | Lymphocytes | PCR-RFLP |
Agalliu, 2010 | Prostate | USA | Caucasian | Retrospective | PB | 1221/1219 | 0.09 | 0.537 | 1 | Lymphocytes | SNPlex |
Agalliu, 2010 | Prostate | USA | African American | Retrospective | PB | 144/81 | 0.02 | 0.539 | 0.489 | Lymphocytes | SNPlex |
Rajaraman, 2010 | Brain | USA | Caucasian | Retrospective | HB | 526/471 | 0.07 | 0.134 | 0.809 | Blood | Quantitative PCR |
Abbasi, 2009 | Larynx | Germany | Caucasian | Retrospective | PB | 248/647 | 0.07 | 0.163 | 0.747 | Buffy coats | Quantitative PCR |
Han, 2009 | Breast | USA | Caucasian | Prospective | PB | 1145/1142 | 0.07 | 0.527 | 0.998 | Blood | BeadArray |
Joshi, 2009 | Colorectal | USA | Caucasian | Retrospective | FB | 305/357 | – | 0.985 | 0.969 | Lymphocytes | Quantitative PCR |
Chang, 2008 | Lung | USA | Latino | Retrospective | PB | 113/299 | 0.06 | 0.331 | 0.609 | Blood, Buccal cells | BeadArray |
Hung, 2008 | Lung | Europe | Caucasian, Asia | Retrospective | PB,HB | 2520/2619 | 0.08 | 0.002 | 0.995 | Blood | Pooled |
McWilliam, 2008 | Pancreatic | USA | Caucasian | Retrospective | HB | 470/596 | 0.10 | 0.003 | 0.418 | Blood | SNPstream, Sequencing |
Rajaraman, 2008 | Breast | USA | Caucasian | Retrospective | PB | 838/1069 | – | 0.516 | 0.995 | Blood | Quantitative PCR |
Smith, 2008 | Breast | USA | Caucasian | Retrospective | HB | 324/406 | 0.01 | 0.342 | 0.826 | Blood | MassArray |
Smith, 2008 | Breast | USA | African American | Retrospective | HB | 53/75 | 0.06 | 0.724 | 0.520 | Blood | MassArray |
Crew, 2007 | Breast | USA | Caucasian | Retrospective | PB | 1018/1065 | 0.09 | 0.535 | 0.999 | Lymphocytes | FP, Sequenom, Quantitative PCR |
Jorgensen, 2007 | Breast | USA | Caucasian | Prospective | PB | 259/275 | 0.08 | 0.671 | 0.920 | Buffy coats | Quantitative PCR |
Huang, 2006 | Colorectal | USA | Mixed | Retrospective | PB | 703/716 | 0.07 | 0.313 | 0.960 | Blood | Pooled |
Mechanic, 2006 | Breast | USA | African American | Retrospective | PB | 757/673 | 0.02 | 0.034 | 0.351 | Lymphocytes | Quantitative PCR, Sequencing |
Mechanic, 2006 | Breast | USA | Caucasian | Retrospective | PB | 1246/1133 | 0.07 | 0.113 | 0.979 | Lymphocytes | Quantitative PCR, Sequencing |
Moreno, 2006 | Colorectal | Spain | Caucasian | Retrospective | HB | 360/323 | 0.11 | 0.693 | 0.969 | Blood | APEX microarray |
Smith, 2003 | Breast | USA | Caucasian | Retrospective | HB | 253/268 | 0.06 | 0.439 | 0.799 | Blood | PCR-RFLP |
XPF-rs1799801 (Ser835Ser) | |||||||||||
Doherty, 2011 | Endometrial | USA | Caucasian | Retrospective | PB | 722/727 | 0.29 | 0.896 | 1 | Blood, Buccal cells | SNPlex, SNaPshot, Quantitative PCR, PCR-RFLP |
Roberts, 2011 | Breast | USA | Caucasian | Retrospective | PB | 1063/1913 | 0.29 | 0.141 | 1 | Blood, mouthwash samples | MassARRAY |
Agalliu, 2010 | Prostate | USA | Caucasian | Retrospective | PB | 1259/1243 | 0.29 | 0.937 | 1 | Lymphocytes | SNPlex |
Agalliu, 2010 | Prostate | USA | African American | Retrospective | PB | 145/79 | 0.16 | 0.603 | 0.806 | Lymphocytes | SNPlex |
Wang, 2010 | Bladder | China | Asian | Retrospective | HB | 234/250 | 0.25 | 0.412 | 0.920 | Blood | PCR-RFLP |
Hooker, 2008 | Prostate | USA | African American | Retrospective | HB | 252/301 | 0.13 | 0.215 | 0.812 | Blood | MassARRAY |
Povey, 2007 | Melanoma | UK | Caucasian | Retrospective | PB | 506/441 | 0.28 | 0.041 | 0.856 | Blood | PCR-RFLP |
Garcia-Closas, 2006 | Bladder | Spain | Caucasian | Retrospective | HB | 1091/1019 | 0.31 | 0.885 | 1 | leukocytes, mouthwash sample | Pooled |
Lee, 2005 | Breast | Korea | Asian | Retrospective | HB | 386/336 | 0.23 | 0.406 | 0.970 | Blood | DASH Hybaid |
Matullo, 2005 | Bladder | UK | Caucasian | Retrospective | HB | 204/213 | 0.32 | 0.340 | 0.865 | buffy coats | Pooled |
Shen, 2005 | Lung | USA | Asian | Retrospective | PB | 117/111 | 0.19 | 0.231 | 0.611 | Sputum | Quantitative PCR |
XPF-rs2020955 (Ser662Pro) | |||||||||||
Rajaraman, 2010 | Brain | USA | Caucasian | Retrospective | HB | 514/444 | 0.00 | 0.917 | 0.589 | Blood | Quantitative PCR |
Hooker, 2008 | Prostate | USA | African American | Retrospective | HB | 254/301 | 0.19 | 0.689 | 0.972 | Blood | MassARRAY |
Garcia-Closas, 2006 | Bladder | Spain | Caucasian | Retrospective | HB | 1066/1001 | 0.01 | 0.859 | 0.854 | leukocytes, mouthwash sample | Pooled |
Mechanic, 2006 | Breast | USA | African American | Retrospective | PB | 752/674 | 0.20 | 0.535 | 0.999 | Lymphocytes | Quantitative PCR, Sequencing |
Mechanic, 2006 | Breast | USA | Caucasian | Retrospective | PB | 249/250 | 0.00 | 0.568 | 0.399 | Lymphocytes | Quantitative PCR, Sequencing |
XPF-rs744154 (intron) | |||||||||||
Wang, 2010 | Bladder | China | Asian | Retrospective | HB | 234/250 | 0.27 | 0.004 | 0.252 | Blood | PCR-RFLP |
Gaudet, 2009 | Breast | Multicenter | Caucasian | Retrospective | PB,HB | 25743/29074 | 0.28 | 0.542 | 1 | Pooled | Quantitative PCR |
Gaudet, 2009 | Breast | Multicenter | African | Retrospective | PB,HB | 651/571 | 0.25 | 0.870 | 1 | Pooled | Quantitative PCR |
Gaudet, 2009 | Breast | Multicenter | Asian | Retrospective | PB,HB | 2700/2104 | 0.24 | 0.345 | 1 | Pooled | Quantitative PCR |
Abbreviation: SNP, single nucleotide polymorphism; HB, Hospital based; PB, Population based; FB, Family based; RFLP, Restriction fragment length polymorphisms.
P value for dominant genetic model in the associations with XPF polymorphisms.
Statistical power to detect an OR of 1.5 (or 0.67 = 1/1.5).